ABVC BioPharma, Inc. (ABVC)

NASDAQ: ABVC · Real-Time Price · USD

1.290

-0.070 (-5.15%)

At close: Feb 26, 2026, 4:00 PM EST

1.300

+0.010 (0.78%)

After-hours: Feb 26, 2026, 5:21 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
Biotechnology (Startups)	509.59K	152.43K	969.78K	355.80K	483.05K
Biotechnology (Startups) Growth	234.31%	-84.28%	172.57%	-26.34%	-31.16%
Total	509.59K	152.43K	969.78K	355.80K	483.05K
Total Growth	234.31%	-84.28%	172.57%	-26.34%	-31.16%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
United States	509.59K	152.43K	969.78K	355.80K	483.05K
United States Growth	234.31%	-84.28%	172.57%	-26.34%	-31.16%
Total	509.59K	152.43K	969.78K	355.80K	483.05K
Total Growth	234.31%	-84.28%	172.57%	-26.34%	-31.16%

Source: S&P Global Market Intelligence.